» Articles » PMID: 30634953

The Association Between Ethnicity, Stigma, Beliefs About Medicines and Adherence in People Living with HIV in a Rural Area in Indonesia

Overview
Publisher Biomed Central
Specialty Public Health
Date 2019 Jan 13
PMID 30634953
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Indonesia is one of Asia's countries with the fastest growing rate of human immunodeficiency virus (HIV) infections according to the World Health Organization (WHO). The prevalence of HIV infections in the province of Papua is 2.4% which is 24 times higher than the national rate in Indonesia. This study aimed to investigate the association between stigma, beliefs about medicines, sociodemographic characteristics including ethnicity and adherence in People living with HIV (PLHIV) in Papua, Indonesia.

Methods: We conducted a cross-sectional study using questionnaires. We included participants from two hospital-outpatient clinics who were on antiretroviral treatment (ART) for more than 6 months, were at least 18 years old, and signed informed consent. Participants completed the Medication Adherence Rating Scale (MARS), Beliefs about Medicines Questionnaire (BMQ), an HIV stigma scale and questions on demographic information. Data on antiretroviral medications were collected from medical records. The outcome was self-reported adherence as measured by the MARS using an 80% cut-off score. Multivariate logistic regression was used to analyse the data.

Results: Overall, 331 out of 363 eligible participants were included with a mean age of 33.3 (± 9.4) years, 61.6% were female, 67.1% were Papuan. A total of 65.9% of participants were adherent. Being Papuan decreased the likelihood of adherence (odds ratio (OR) = 0.53; 95% confidence interval (CI) = 0.32-0.89). Feeling more distant, a stigma type, also decreased the likelihood of adherence (OR = 0.93; 95% CI = 0.88-0.99).

Conclusion: The ethnicity of being Papuan and taking a distance to others were associated with non-adherence. Targeted interventions should be developed to improve adherence in this group.

Citing Articles

A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality.

Merati T, Yunihastuti E, Wisaksana R, Kurniati N, Arlinda D, Karyana M BMC Infect Dis. 2025; 25(1):87.

PMID: 39833697 PMC: 11748832. DOI: 10.1186/s12879-024-10354-8.


The Relationship between Distress Tolerance and Spiritual Well-Being towards ARV Therapy Adherence in People Living with HIV/AIDS.

Saputra R, Waluyo A, Edison C Healthcare (Basel). 2024; 12(8).

PMID: 38667601 PMC: 11050109. DOI: 10.3390/healthcare12080839.


Determinants of quality of life among people with HIV and tuberculosis in an underserved area in Indonesia: a cross-sectional study.

Sianturi E, Izzah Z, Huda K, Sada E, Perwitasari D, Mantiri S Pan Afr Med J. 2024; 46:61.

PMID: 38282780 PMC: 10822095. DOI: 10.11604/pamj.2023.46.61.41521.


Barriers and Facilitators to HIV Treatment Adherence in Indonesia: Perspectives of People Living with HIV and HIV Service Providers.

Hutahaean B, Stutterheim S, Jonas K Trop Med Infect Dis. 2023; 8(3).

PMID: 36977140 PMC: 10056901. DOI: 10.3390/tropicalmed8030138.


Factors influencing adherence to anti-retroviral therapy in amazonian indigenous people living with HIV/AIDS.

Valenzuela-Ore F, Angulo-Bazan Y, Lazoriga-Sandoval L, Cruz-Vilcarromero N, Cubas-Sagardia C BMC Public Health. 2023; 23(1):497.

PMID: 36922774 PMC: 10015934. DOI: 10.1186/s12889-023-15362-y.


References
1.
Shubber Z, Mills E, Nachega J, Vreeman R, Freitas M, Bock P . Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Med. 2016; 13(11):e1002183. PMC: 5127502. DOI: 10.1371/journal.pmed.1002183. View

2.
Rosenblum M, Deeks S, van der Laan M, Bangsberg D . The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One. 2009; 4(9):e7196. PMC: 2747009. DOI: 10.1371/journal.pone.0007196. View

3.
Farber E, Shahane A, Brown J, Campos P . Perceived stigma reductions following participation in mental health services integrated within community-based HIV primary care. AIDS Care. 2013; 26(6):750-3. DOI: 10.1080/09540121.2013.845285. View

4.
Thompson K, Kulkarni J, Sergejew A . Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000; 42(3):241-7. DOI: 10.1016/s0920-9964(99)00130-9. View

5.
Genberg B, Lee Y, Rogers W, Wilson I . Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav. 2014; 19(1):85-92. PMC: 4203705. DOI: 10.1007/s10461-014-0775-2. View